In a glioma mouse model, TLS can be triggered near the meninges by systemic delivery of αCD40 in a CD11b+ B cell-dependent manner, which is expected to improve the immunosuppressive TME of glioma (75). The gene discussed is ITGAM; the disease is central nervous system cancer.